Applications and perspectives of boron-enriched nanocomposites in cancer therapy

Future Medicinal Chemistry

Volumn 5, Issue 6, 2013, Pages 705-714

  Yinghuai, Zhu ^a   Hosmane, Narayan S ^b  

^a INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

^b NORTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BORONOPHENYLALANINE; BORON 10; BORON DERIVATIVE; BORON NITRIDE NANOTUBE; CARBON NANOTUBE; LIPOSOME; MAGNETIC NANOPARTICLE; NANOCOMPOSITE; NANOPARTICLE; SODIUM MERCAPTODODECABORATE; UNCLASSIFIED DRUG;

BRAIN CANCER; CANCER THERAPY; NANOENCAPSULATION; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; HUMANS; NANOCOMPOSITES; NANOPARTICLES; NANOTUBES;

EID: 84876883018     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.47     Document Type: Review

References (77)

1. Soloway AH, Tjarks W, Bauman BA et al. The chemistry of neutron capture therapy. Chem. Rev. 98, 1515-1562 (1998
2. Hawthorne MF. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew. Chem. Int. Ed. 32, 950-984 (1993
3. Wara WM, Bauman GS, Sneed PK et al. Brain, brain stem, and cerebellum In: Principles and Practice of Radiation Oncology (3rd edition). Perez CA, Brady LW (Eds). Lippincott-Raven, PA, USA, 777-828 (1998
4. Fairchild RG, Bond VP. Current status of 10B-neutron capture therapy: Enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluation. Int. J. Radiat. Oncol. Biol. Phys. 11, 831-840 (1985
5. Barth RF, Coderre JA, Vicente MGH, Blue TE. Boron neutron capture therapy of cancer: Current status and future prospects. Clin. Cancer. Res. 11, 3987-4002 (2005
6. Laws ER, Shaffrey ME. The inherent invasiveness of cerebral gliomas: Implications for clinical management. Int. J. Dev. Neurosci. 17, 413-420 (1999
7. Perry A, Schmidt RE. Cancer therapy-Tssociated CNS neuropathology: An update and review of the literature. Acta Neuropathol. 111, 197-212 (2006
8. Kouri M, Kankaanranta L, Seppälä T et al. Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy. Radiother. Oncol. 72, 83-85 (2004
9. Hariharan JR, Wyzlic IM, Soloway AH. Synthesis of novel boron-containing polyamines -Tgents for DNA targeting in neutron capture therapy. Polyhedron 14, 823-829 (1995
10. Byun Y, Narayanasamy S, Johnsamuel J et al. 3-carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy. Anticancer Agents Med. Chem. 6, 127-144 (2006
11. Renner MW, Miura M, Easson MW, Vicente MGH. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy. Anticancer Agents Med. Chem. 6, 145-157 (2006
12. Ol'shevskaya VA, Guil'malieva MA, Zaitsev AV et al. Boron-containing porphyrins: A new synthetic approach. In: Boron Chemistry at the Beginning of the 21st Century. Moscow, Russian Federation, 327-323 (2002
13. Shelly K, Feakes DA, Hawthorne MF, Schmidt PG, Krisch TA, Bauer WF. Model studies directed toward the boron neutron-capture therapy of cancer: Boron delivery to murine tumors with liposomes. Proc. Natl Acad. Sci. USA 89, 9039-9043 (1992
14. Radel PA, Kahl SB. Enantioselective synthesis of l- And d-carboranylalanine. J. Org. Chem. 61, 4582-4588 (1996
15. Kabalka GW, Yao ML. The synthesis and use of boronated amino acids for boron neutron capture therapy. Anticancer Agents Med. Chem. 6, 111-125 (2006
16. Fukuda H, Hiratsuka J, Honda C et al. Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the skin. Radiat. Res. 138, 435- 442 (1994
17. Coderre JA, Elowitz EH, Chadha M et al. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results. J. Neurooncol. 33, 141-152 (1997
18. Elowitz EH, Bergland RM, Coderre JA, Joel DD, ChadhaM, Chanana AD. Biodistribution of p-boronophenylalanine inpatientswith glioblastomamultiforme for use in boron neutron capture therapy. Neurosurgery 42, 463-469 (1998
19. Soloway AH, Hatanaka H, Davis MA. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J. Med. Chem. 10, 714-717 (1967
20. Hatanaka H, Nakagawa Y. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28, 1061-1066 (1994
21. Mishima Y. Cancer Neutron Capture Therapy. Mishima Y (Ed.). Plenum Press, NY, USA, 1-26 (1996
22. Van Rij CM, Wilhelm AJ, Sauerwein W, van Loenen A. Boron neutron capture therapy for glioblastoma multiforme. Pharm. World Sci. 27, 92-95 (2005
23. Jain RK. Normalizing the tumor vasculature with anti-Tngiogenic therapy: A new paradigm for combination therapy. Nat. Med. 7, 987-989 (2001
24. Santini J, Cima M, Langer R. A controlled-release microchip. Nature 397, 335-338 (1999
25. Sartor O, Dineen MK, Perez-Marreno R, Chu FM, Carron GJ, Tyler RC. An eight-month clinical study of LA-2575 30.0 mg: A new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer. Urology 62, 319-323 (2003
26. Chen W, Mehta SC, Lu DR. Selective boron drug delivery to brain tumors for boron neutron capture therapy. Adv. Drug Delivery Rev. 26, 231-247 (1997
27. Wu G, Barth RF, Yang W et al. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anticancer Agents Med. Chem. 6, 167-184 (2006
28. Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J. Cell Biochem. 97, 1184-1190 (2006
29. Hobbs K, Monsky W, Yuan F et al. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl Acad. Sci. USA 95, 4607-4612 (1998
30. Kreuter J, Alyyautidin RN, Kharkevich DA, Ivanov AA. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 674, 171-174 (1995
31. Zhu Y, Koh CY, Maguire JA, Hosmane NS. Recent developments in boron neutron capture therapy driven by nanotechnology. Curr. Chem. Biol. 1, 141-149 (2007
32. Hosmane NS, Maguire JA, Zhu Y, Takagaki M. Boron and Gadolinium Neutron Capture Therapy for Cancer Treatment. World Scientific Publishing Co. Pte. Ltd, Singapore, 52-88 (2012
33. Alexiou C, Arnold W, Klein RJ et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60, 6641-6648 (2000
34. Lee H, Yu MK, Park S et al. Thermally cross-linked superparamagnetic iron oxide nanoparticles: Synthesis and application as a dual imaging probe for cancer in vivo. J. Am. Chem. Soc. 129, 12739-12745 (2007
35. Allard E, Passirani C, Benoit JP. Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials 30, 2302-2318 (2009
36. Salata OV. Applications of nanoparticles in biology and medicine. J. Nanobiotech. 2, 3-8 (2004
37. Landeghem FKH, Maier-Hauff K, Jordan A et al. Post-morten studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30, 52-57 (2009
38. Lübbe AS, Bergemann C, Riess H et al. Clinical experiences with magnetic drug targeting: A Phase I study with 4́-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 56, 4686-4693 (1996
39. Pulfer SK, Gallo JM. Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. J. Drug. Target. 6, 215-227 (1998
40. Alexiou C, Jurgons R, Schmid RJ et al. Magnetic drug targeting- biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J. Drug Target. 11, 139-149 (2003
41. Pulfer SK, Ciccotto SL, Gallo JM. Distribution of small magnetic particles in brain tumor-bearing rats. J. Neuro-Oncology 41, 99-105 (1999
42. Sincai M, Ganga D, Ganga M, Argherie D, Bica D. Antitumor effect of magnetite nanoparticles in cat mammary adenocarcinoma. J. Magn. Magn. Mater. 293, 438-441 (2005
43. Chertok B, Moffat BA, David AE et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29, 487-496 (2008
44. Zhu Y, Lin Y, Zhu YZ, Lu J, Maguire, JA, Hosmane NS. Boron drug delivery via encapsulated magnetic nanocomposites: A new approach for BNCT in cancer treatment. J. Nanomater. 2010, 409320 (2010
45. Mortensen MW, Björkdahl O, Sørensen PG et al. Functionalization and cell uptake of boron carbide nanoparticles. The first step toward T cell-guided boron neutron capture therapy. Bioconj. Chem. 17, 284-290 (2006
46. Petersen MS, Petersen CC, Agger R et al. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model. Antican. Res. 28, 571-576 (2008
47. Sumitani S, Oishi M, Nagasaki Y. Carborane confined nanoparticles for boron neutron capture therapy: Improved stability, blood circulation time and tumor accumulation. React. Funct. Polym. 71, 684-693 (2011
48. Sumitani S, Oishi M, Yaguchi T et al. Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer. Biomaterials 33, 3568-3577 (2012
49. Gao Z, Walton NI, Malugin A, Ghandehari H, Zharov I. Preparation of dopamine-modified boron nanoparticles. J. Mater. Chem. 22, 877-882 (2012
50. Grandi S, Spinella A, Tomasi C et al. Synthesis and characterization of functionalized borosilicate nanoparticles for boron neutron capture therapy applications. J. Sol-Gel. Sci. Technol. 64, 358-366 (2012
51. Iijma S. Helical microtubules of graphitic carbon. Nature 354, 56-58 (1991
52. De Volder MFL, Tawfick SH, Baughman RH, Hart AJ. Carbon nanotubes: Present and future commercial applications. Science. 339, 535-539 (2013
53. Cuenca A, Jiang H, Hochwald S, Delano M, Cance W, Grobmyer S. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 107, 459-466 (2006
54. Aqel A, Abou El-Nour KMM, Ammar RAA, Al-Warthan A. Carbon nanotubes, science and technology part (I) structure, synthesis and characterization. Arabian J. Chem. 5(1), 1-23 (2010
55. Pantarotto D, Briand JP, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. 1, 16-17 (2004
56. Cherukuri P, Bachilo SM, Litovsky SH, Weisman RB. Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J. Am. Chem. Soc. 126, 15638-15639 (2004
57. Kam NW, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad. Sci. USA 102, 11600-11605 (2005
58. Liu Z, Cai W, He L et al. In vivo biodistribution and highly efficient tumor targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2, 47-52 (2007
59. Zhu YH, Ang TP, Carpenter K, Maguire J, Hosmane N, Takagaki M. Substituted carborane-Tppended water soluble single-wall carbon nanotubes: New approach to boron neutron capture therapy drug delivery. J. Am. Chem. Soc. 127, 9875-9880 (2005
60. Chopra NG, Luyken RJ, Cherrey K et al. Boron nitride nanotubes. Science 269, 966-967 (1995
61. Han WQ, Mickelson W, Cumings J, Zettl A. Transformation of BxCyNz nanotubes to pure BN nanotubes. Appl. Phys. Lett. 81, 1110-1112 (2002
62. Golberg D, Bando Y, Tang CC, Zhi CY, Boron nitride nanotubes. Adv. Mater. 19, 2413-2432 (2007
63. Yu J, Chen Y, Elliman RG, Petravic M. Isotopically enriched 10BN nanotubes. Adv. Mater. 18, 2157-2160 (2006
64. Chen X, Wu P, Rousseas M et al. Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells. J. Am. Chem. Soc. 131, 890-891 (2009
65. Ciofani G, Raffa V, Menciassi A, Cuschieri A. Folate functionalised boron nitride nanotubes and their selective uptake by glioblastoma multiforme cells: Implications for their use as boron carriers in clinical boron neutron capture therapy. Nanoscale Res. Lett. 4, 113-121 (2009
66. Ciofani G. Potential applications of boron nitride nanotubes as drug delivery systems. Expert Opin. Drug Deliv. 7, 889-893 (2010
67. Menichetti L, De Marchi D, Calucci L, Ciofani G, Menciassi A, Forte C. Boron nitride nanotubes for boron neutron capture therapy as contrast agents in magnetic resonance imaging at 3 T. Appl. Radiat. Isot. 69, 1725-1727 (2011
68. Ciofani G, Del Turco S, Genchi GG, D'Alessandro D, Basta G, Mattoli V. Transferrin-conjugated boron nitride nanotubes: Protein grafting, characterization, and interaction with human endothelial cells. Int. J. Pharm. 436, 444-453 (2012
69. Liu F, Shen C, Zanjia SZ et al. Metal-like single crystalline boron nanotubes: Synthesis and in situ study on electric transport and field emission properties. J. Mater. Chem. 20, 2197-2205 (2010
70. Gregoriadis G, Florence AT. Liposomes for drug deliver. Drugs 45, 15-28 (1993
71. Gabizon A, Price DC, Huberty J, Bresalier RS, Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies. Cancer Res. 50, 6371-6378 (1990
72. Torchilin P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug. Discov. 4, 145-160 (2005
73. Ristori S, Oberdisse J, Grillo I, Donati A, Spalla O. Structural characterization of cationic liposomes loaded with sugar-based carboranes. Biophys. J. 88, 535-547 (2005
74. Yanagie H, Matuyama K, Takizawa T et al. Application of boron-entrapped stealth liposomes to inhibition of growth of tumor cells in the in vivo boron neutron-capture therapy model. Biomed. Pharmacother. 60, 43-50 (2006
75. Nobuto H, Sugita T, Kubo T et al. Evaluation of systematic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int. J. Cancer 109, 627-635 (2004
76. Nakamura H, Ueda N, Hyun SB, Ueno M, Tachikawa S. Design and synthesis of fluorescence-labeled closo-dodecaborate lipid: Its liposome formation and in vivo imaging targeting of tumors for boron neutron capture therapy. Org. Biomol. Chem. 10, 1374-1380 (2012
77. Koganei H, Ueno M, Tachikawa S et al. Development of high boron content liposomes and their promising antitumor effect for neutron capture of cancers. Bioconj. Chem. 24, 124-132 (2013